267 related articles for article (PubMed ID: 34406042)
41. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
42. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
Zhang WW; Matlashewski G
mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
[TBL] [Abstract][Full Text] [Related]
43. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
44. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
[TBL] [Abstract][Full Text] [Related]
45. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P
Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785
[TBL] [Abstract][Full Text] [Related]
46. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
Liu GG; Li S; Wei YD; Zhang YX; Ding QR
Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
[TBL] [Abstract][Full Text] [Related]
47. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
[TBL] [Abstract][Full Text] [Related]
48. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
[TBL] [Abstract][Full Text] [Related]
49. CRISPR-Cas9 assisted non-homologous end joining genome editing system of Halomonas bluephagenesis for large DNA fragment deletion.
Liu C; Yue Y; Xue Y; Zhou C; Ma Y
Microb Cell Fact; 2023 Oct; 22(1):211. PubMed ID: 37838676
[TBL] [Abstract][Full Text] [Related]
50. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.
Hou Z; Zhang Y; Propson NE; Howden SE; Chu LF; Sontheimer EJ; Thomson JA
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15644-9. PubMed ID: 23940360
[TBL] [Abstract][Full Text] [Related]
51. Towards mastering CRISPR-induced gene knock-in in plants: Survey of key features and focus on the model Physcomitrella patens.
Collonnier C; Guyon-Debast A; Maclot F; Mara K; Charlot F; Nogué F
Methods; 2017 May; 121-122():103-117. PubMed ID: 28478103
[TBL] [Abstract][Full Text] [Related]
52. CRISPR/Cas9 Technology in Translational Biomedicine.
Leonova EI; Gainetdinov RR
Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
[TBL] [Abstract][Full Text] [Related]
53. Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing.
Guo T; Feng YL; Xiao JJ; Liu Q; Sun XN; Xiang JF; Kong N; Liu SC; Chen GQ; Wang Y; Dong MM; Cai Z; Lin H; Cai XJ; Xie AY
Genome Biol; 2018 Oct; 19(1):170. PubMed ID: 30340517
[TBL] [Abstract][Full Text] [Related]
54. Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA.
Liang X; Potter J; Kumar S; Ravinder N; Chesnut JD
J Biotechnol; 2017 Jan; 241():136-146. PubMed ID: 27845164
[TBL] [Abstract][Full Text] [Related]
55. Proximal binding of dCas9 at a DNA double strand break stimulates homology-directed repair as a local inhibitor of classical non-homologous end joining.
Feng YL; Liu SC; Chen RD; Sun XN; Xiao JJ; Xiang JF; Xie AY
Nucleic Acids Res; 2023 Apr; 51(6):2740-2758. PubMed ID: 36864759
[TBL] [Abstract][Full Text] [Related]
56. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
Elife; 2022 Sep; 11():. PubMed ID: 36069759
[TBL] [Abstract][Full Text] [Related]
57. Controlling Ratios of Plasmid-Based Double Cut Donor and CRISPR/Cas9 Components to Enhance Targeted Integration of Transgenes in Chinese Hamster Ovary Cells.
Shin SW; Kim D; Lee JS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673701
[TBL] [Abstract][Full Text] [Related]
58. Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases.
Merkert S; Martin U
Adv Biochem Eng Biotechnol; 2018; 163():169-186. PubMed ID: 29124278
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
Santos DP; Kiskinis E; Eggan K; Merkle FT
Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
[TBL] [Abstract][Full Text] [Related]
60. Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System.
Xue H; Wu J; Li S; Rao MS; Liu Y
Methods Mol Biol; 2016; 1307():173-90. PubMed ID: 24615461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
